Full text is available at the source.
Psychedelic renaissance: Revitalized potential therapies for psychiatric disorders
Renewed promise of psychedelics as treatments for mental health disorders
AI simplified
Abstract
Psychedelic substances may have therapeutic potential for psychiatric disorders, which are the largest cause of disability worldwide.
- Psychedelic compounds such as psilocybin, DMT, LSD, and MDMA are being explored for their potential therapeutic effects.
- Safety concerns associated with these substances are also reviewed.
- The interactive effects of psychedelics combined with psychotherapeutic approaches are discussed.
- The review includes findings from active and recently completed clinical trials.
- Sources include published literature, conference abstracts, and clinical trial registries.
AI simplified